SMDAM
Sumitomo Mitsui DS Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Buy |
42,630
+832
| +2% | +$30K | 0.01% | 551 |
|
|
2025
Q1 | $1.3M | Buy |
41,798
+13,615
| +48% | +$424K | 0.01% | 573 |
|
|
2024
Q4 | $719K | Hold |
28,183
| – | – | 0.01% | 670 |
|
|
2024
Q3 | $797K | Hold |
28,183
| – | – | 0.01% | 655 |
|
|
2024
Q2 | $743K | Buy |
28,183
+12
| +0% | +$316 | 0.01% | 647 |
|
|
2024
Q1 | $856K | Sell |
28,171
-56
| -0.2% | -$1.7K | 0.01% | 623 |
|
|
2023
Q4 | $793K | Hold |
28,227
| – | – | 0.01% | 655 |
|
|
2023
Q3 | $766K | Sell |
28,227
-64
| -0.2% | -$1.74K | 0.01% | 614 |
|
|
2023
Q2 | $870K | Hold |
28,291
| – | – | 0.01% | 594 |
|
|
2023
Q1 | $1.02M | Buy |
28,291
+6,377
| +29% | +$230K | 0.02% | 540 |
|
|
2022
Q4 | $866K | Hold |
21,914
| – | – | 0.02% | 550 |
|
|
2022
Q3 | $881K | Buy |
21,914
+2,665
| +14% | +$107K | 0.02% | 523 |
|
|
2022
Q2 | $809K | Hold |
19,249
| – | – | 0.02% | 535 |
|
|
2022
Q1 | $750K | Hold |
19,249
| – | – | 0.02% | 579 |
|
|
2021
Q4 | $767K | Buy |
19,249
+11,216
| +140% | +$447K | 0.02% | 586 |
|
|
2021
Q3 | $290K | Sell |
8,033
-54
| -0.7% | -$1.95K | 0.01% | 716 |
|
|
2021
Q2 | $331K | Hold |
8,087
| – | – | 0.01% | 711 |
|
|
2021
Q1 | $352K | Buy |
8,087
+1,731
| +27% | +$75.3K | 0.01% | 688 |
|
|
2020
Q4 | $318K | Buy |
+6,356
| New | +$318K | 0.01% | 685 |
|